12 news items
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
ALBT
ANNX
BARK
4 Jun 24
.
Sequans Communications SA ADR (NYSE:SQNS) shares fell 11.9
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen's Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials
FGEN
3 Jun 24
, Marketing and Corporate Communications
FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors
FGEN
3 Jun 24
:Simon MillerVice President, Marketing and Corporate Communications
f4elhnxfp2q 2p
BNTX
CTMX
FGEN
3 Jun 24
your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult
sincxpnut5 ua7dds
BNTX
CTMX
FGEN
3 Jun 24
to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult
ettta9 ptccpm6h59843pxsg7vjl1pqfxcciremtb596
FGEN
23 May 24
@fibrogen.com For Media Inquiries:Meichiel KeenanDirector, Investor Relations and Corporate Communications
0xhqb1mm62rjtlb9pg73dr5im bx7gvs4
FGEN
6 May 24
:Meichiel KeenanDirector, Investor Relations and Corporate Communicationsmedia@fibrogen.com
ab3s eq1exvh
FGEN
29 Apr 24
with the investment community to further detail the company's corporate and financial performance. Conference Call and Audio Webcast
hxxwrzomw8u0fh9k4z iq7sc24z
FGEN
24 Apr 24
Relations and Corporate Communications
kps45l712idprbk4 dpcabpn2osz5
FGEN
2 Apr 24
@fibrogen.com Media:Meichiel KeenanDirector, Investor Relations and Corporate Communications
- Prev
- 1
- Next